Dr Reddy's licenses insulin sensitiser to Novo Nordisk
Dr Reddy's licenses insulin sensitiser to Novo Nordisk
Dr Reddy's Research Foundation (DRF), part of the Dr. Reddy's group, has licensed another new chemical entity (NCE) developed by it to the Denmark-based Novo Nordisk, the world leader in insulin and
Publication Date:
12/12/1997